100000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Disclosure - Leases (Details) - Schedule of Operating and Finance Lease Including the Remaining Lease payments Through the end of the Expected Lease Term 2
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited) (Parentheticals)
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995453 - Disclosure - The Company and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995463 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995473 - Disclosure - Fair Value Measurement
link:presentationLink
link:calculationLink
link:definitionLink
995483 - Disclosure - Accounts Receivable, Non-trade
link:presentationLink
link:calculationLink
link:definitionLink
995493 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995503 - Disclosure - Goodwill
link:presentationLink
link:calculationLink
link:definitionLink
995513 - Disclosure - Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
995523 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995533 - Disclosure - Share Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995543 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995553 - Disclosure - Capital stock
link:presentationLink
link:calculationLink
link:definitionLink
995563 - Disclosure - License Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995573 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995583 - Disclosure - Net Income (Loss) per Share
link:presentationLink
link:calculationLink
link:definitionLink
995593 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995603 - Disclosure - Contingent Consideration
link:presentationLink
link:calculationLink
link:definitionLink
995613 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995623 - Disclosure - Immaterial Correction of Prior Quarter Error
link:presentationLink
link:calculationLink
link:definitionLink
995633 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995643 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995653 - Disclosure - The Company and Basis of Presentation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995663 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995673 - Disclosure - Fair Value Measurement (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995683 - Disclosure - Accounts Receivable, Non-trade (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995693 - Disclosure - Property and Equipment, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995703 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995713 - Disclosure - Goodwill (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995723 - Disclosure - Intangible Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995733 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995743 - Disclosure - Share Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995753 - Disclosure - Warrants (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995763 - Disclosure - Net Income (Loss) per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995773 - Disclosure - Contingent Consideration (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995783 - Disclosure - Immaterial Correction of Prior Quarter Error (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995793 - Disclosure - The Company and Basis of Presentation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995803 - Disclosure - The Company and Basis of Presentation (Details) - Schedule of Company’s Entity Structure at the End of the Reporting Period
link:presentationLink
link:calculationLink
link:definitionLink
995813 - Disclosure - Summary of Significant Accounting Policies (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995823 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of the Property and Equipment
link:presentationLink
link:calculationLink
link:definitionLink
995833 - Disclosure - Fair Value Measurement (Details) - Schedule of Company’s Liabilities at Fair Value on a Recurring Basis
link:presentationLink
link:calculationLink
link:definitionLink
995843 - Disclosure - Fair Value Measurement (Details) - Schedule of Fair Value was Determined by Level 3 Inputs
link:presentationLink
link:calculationLink
link:definitionLink
995853 - Disclosure - Accounts Receivable, Non-trade (Details) - Schedule of Accounts Receivable, Non-Trade
link:presentationLink
link:calculationLink
link:definitionLink
995863 - Disclosure - Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995873 - Disclosure - Leases (Details) - Schedule of Operating and Finance Lease Including the Remaining Lease payments Through the end of the Expected Lease Term
link:presentationLink
link:calculationLink
link:definitionLink
995883 - Disclosure - Leases (Details) - Schedule of Effect of Lease Costs in our Condensed Consolidated Statements of Operations and Comprehensive (Income) Loss
link:presentationLink
link:calculationLink
link:definitionLink
995893 - Disclosure - Goodwill (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995903 - Disclosure - Goodwill (Details) - Schedule of Carrying Value of Goodwill
link:presentationLink
link:calculationLink
link:definitionLink
995913 - Disclosure - Intangible Assets (Details) - Schedule of Intellectual Property Capitalized
link:presentationLink
link:calculationLink
link:definitionLink
995923 - Disclosure - Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995933 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995943 - Disclosure - Share Based Compensation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995953 - Disclosure - Share Based Compensation (Details) - Schedule of Summarizes Employee and Non-Employee Stock Option Activity
link:presentationLink
link:calculationLink
link:definitionLink
995963 - Disclosure - Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995973 - Disclosure - Warrants (Details) - Schedule of Warrant Activity
link:presentationLink
link:calculationLink
link:definitionLink
995983 - Disclosure - Warrants (Details) - Schedule of Classification, Expiration Date, and Exercise Price of Individual Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995993 - Disclosure - Capital Stock (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996003 - Disclosure - License Revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996013 - Disclosure - Income Taxes (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996023 - Disclosure - Net Income (Loss) per Share (Details) - Schedule of Compilation of Diluted Earnings Per Share
link:presentationLink
link:calculationLink
link:definitionLink
996033 - Disclosure - Net Income (Loss) per Share (Details) - Schedule of Potential Shares of Common Stock
link:presentationLink
link:calculationLink
link:definitionLink
996043 - Disclosure - Related Party Transactions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996053 - Disclosure - Contingent Consideration (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996063 - Disclosure - Contingent Consideration - Summary of Contingent Consideration Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996073 - Disclosure - Commitments and Contingencies (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996083 - Disclosure - Immaterial Correction of Prior Quarter Error (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996093 - Disclosure - Immaterial Correction of Prior Quarter Error - Summary of Immaterial Corrections to Previously Reported Financial Statements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996103 - Disclosure - Subsequent Events (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Termination Fee Paid and Recognized
Termination fee paid and recognized.
Statement [Line Items]
Accounts receivable, non-trade
Increase (Decrease) in Accounts Receivable
Plan Name [Domain]
Schedule of Warrant Activity
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Entity Address, Postal Zip Code
Entity Incorporation, State or Country Code
Other comprehensive loss:
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Contingent Consideration [Abstract]
Operating segment
Number of Operating Segments
Share issued (in Shares)
Stock Issued During Period, Shares, Employee Stock Ownership Plan
Weighted Average Exercise Price per Share, Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Multi Core Technology [Member]
Multi Core Technology.
MultiCore [Member]
Balance (in Shares)
Balance (in Shares)
Shares, Outstanding
Cancer Stem Cell Technology [Member]
Cancer Stem Cell Technology Member
Non-cash rent expense
Other Noncash Income (Expense)
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
Schedule of Summarizes Employee and Non-Employee Stock Option Activity [Line Items]
Contingent Consideration In A Business Combination Member
Contingent Consideration in a Business Combination [Member]
Contingent Consideration In ABusiness Combination Member
Schedule of Operating and Finance Lease Including the Remaining Lease payments Through the end of the Expected Lease Term
Schedule of Operating and Finance Lease including the remaining lease payments Through the end of the expected Lease Term Table Text Block
Schedule of Operating and Finance Lease including the remaining lease payments Through the end of the expected Lease Term Table Text Block
Schedule of Accrued Expenses [Abstract]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year, Total
Remainder of 2025
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Leases
Lessee, Operating Leases [Text Block]
Salary and benefits
Accrued Salaries, Current
Stock, Class of Stock [Table]
Schedule of Fair Value was Determined by Level 3 Inputs
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Contingent Consideration Activity
Deferred tax liability
Deferred Income Tax Liabilities, Net
Citibank Depository Agreement [Member]
Citibank depository agreement.
Citibank Depository Agreement [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Related Party Transactions [Line Items]
Equity [Text Block]
Capital stock
Annual allocation
Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP
Title and Position [Axis]
Class of Warrant or Right [Axis]
Estimated useful
Finite-Lived Intangible Asset, Useful Life
Entity Central Index Key
Central Index Key
Warrant [Member]
Warrant [Member]
Monthly fee
Payment for Management Fee
Subsidiary of LLC or LP [Table]
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Ordinary shares, shares issued
Common Stock, Shares, Issued
Common stock shares issued under ATM facility
Prepaid insurance expense
Increase (Decrease) in Prepaid Expense and Other Assets
The Company and Basis of Presentation
Business Description and Basis of Presentation [Text Block]
Other change in transaction price
Other change in transaction price.
Income Statement [Abstract]
Entity Address, State or Province
Employee share plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Total
Loss before taxes:
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income (loss) before income tax expense
Revision of Prior Period [Axis]
Recently Issued Accounting Pronouncements Not Yet Adopted
Disclosure of accounting policy for recently issued accounting pronouncements not yet adopted.
Recently Issued Accounting Pronouncements Not Yet Adopted Policy Text Block
Class of Warrant or Right [Table]
Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of the Property and Equipment [Table]
Schedule Of Fair Value Was Determined By Level3 Inputs Abstract
Schedule Of Fair Value Was Determined By Level 3 Inputs Abstract
Schedule of Useful Lives of the Property and Equipment
Tabular disclosure of useful lives of the property and equipment.
Scheduleof Useful Livesof The Property And Equipment Table Text Block
Bonus payment payable
Bonus payable.
Bonus Payable
Fixed remuneration
Salary and Wage, Officer, Excluding Cost of Good and Service Sold
Research and development expenses
Research and development expenses.
Research And Development Expenses
Operating lease costs
Lease, Cost [Abstract]
Aggregate Intrinsic Value, Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Working capital
Working capital deficit.
Working Capital Deficit
Country of Incorporation
Subsidiary of Limited Liability Company or Limited Partnership, State
Cover [Abstract]
Subsequent Events [Line Items]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease), Total
Change in fair value
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Comprehensive Loss
Comprehensive Income, Policy [Policy Text Block]
Earnings Per Share, Basic, Total
Net income per share - basic
Net income (loss) per share - basic
Earnings Per Share, Basic
Weighted Average Exercise Price per Share, Lapsed
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price
Operating expenses:
Operating Expenses [Abstract]
Percentage of incentive bonus
Management and Service Fees, Incentive Rate
Contingent Consideration in a Business Combination, Balance at ending
Contingent Consideration in a Business Combination, Balance at beginning
Contingent consideration
Contingent Consideration Classified as Equity, Fair Value Disclosure
Contingent Consideration in a Business Combination, Change in fair value
Change in fair value of contingent consideration
Represent the amount of change in fair value of contingent consideration.
Change In Fair Value Of Contingent Consideration
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Plan Name [Axis]
Number of Options, Outstanding Beginning Balance
Number of Options, Outstanding Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Research and development incentive award
The amount of research and development incentive award.
Research And Development Incentive Award
Current assets:
Assets, Current [Abstract]
Collection of subscription receivable, value
Collection of subscription receivable, value.
Collection of subscription receivable
Schedule Of Summarizes Employee And Non Employee Stock Option Activity Abstract
Cash for operating activities
Net Cash Provided by (Used in) Operating Activities
Net cash provided by (used in) operating activities
Entity Address, Country
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated other comprehensive loss, net of tax
Accumulated Other Comprehensive Income (Loss), Net of Tax
Lease term
Lessee, Operating Lease, Term of Contract
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Fair Value, Recurring [Member]
Fair Value, Recurring [Member]
Commitments and Contingencies (Details) [Table]
Common stock, par value
Common Stock, Par or Stated Value Per Share
Intangible Assets
Intangible Assets Disclosure [Text Block]
Measurement Input Type [Domain]
Statement of Cash Flows [Abstract]
Counterparty Name [Axis]
Antidilutive Securities, Name [Domain]
Neuporia Therapeutics, Inc. [Member]
Neuporia Therapeutics, Inc.
Neuporia Therapeutics, Inc. [Member]
Weighted Average Exercise Price, Exercised
Class of Warrant or Right, Exercise Price of Warrants or Rights Exercised
Class of warrant or right, exercise price of warrants or rights exercised.
Number of warrants to be issued (in Shares)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Revision of Prior Period, Error Correction, Adjustment [Member]
Error Correction Adjustment [Member]
Facility restoration costs
Facility restoration costs.
Facility Restoration Costs
Equity Components [Axis]
Entity Address, Address Line One
Schedule of Compilation of Diluted Earnings Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Intangible Asset, Finite-Lived [Table]
Computer equipment [Member]
Computer Equipment [Member]
Schedule of Useful Lives of the Property and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Subsequent Event Type [Axis]
Stock Options [Member]
Equity Option [Member]
Total other income (loss)
Nonoperating Income (Expense)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Potential Shares of Common Stock
Accounts Receivable, Non-trade [Abstract]
Warrants (Details) [Table]
Minimum bid price requirement
Minimum Bid Price Requirement
Minimum bid price requirement.
Amendment Flag
Vested and exercisable
Class of Warrant or Right, Vested and exercisable
Class of warrant or right, vested and exercisable.
Net issue costs associated with ADS shares and ADS pre-funded warrants
Net Issue Costs Associated With ADS Shares and ADS Pre-funded Warrants
Net issue costs associated with ads shares and ads pre-funded warrants.
Operating lease liabilities
Increase (Decrease) in Operating Lease Liability
Operating lease liability, net of current portion
Non-current operating lease liabilities
Operating lease liability, long-term
Operating Lease, Liability, Noncurrent
Unrealized Gain (Loss), Foreign Currency Transaction, after Tax
Unrealized loss on foreign currency translation
Net losses
Net Income (loss)
Net income (loss)
Exercise of pre-funded ADS warrants (in Shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Equity awards issued during period
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Number of Options, Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Equity Component [Domain]
Statistical Measurement [Domain]
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Contingent consideration
Business Combination, Contingent Consideration, Liability, Noncurrent
Goodwill [Abstract]
Furniture and office equipment [Member]
Furniture and Fixtures [Member]
Reconciliation of cash, cash equivalents, and restricted cash:
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Consulting fees
Consulting fees.
Consulting Fees
License Revenue
License Revenue [Text Block]
License revenue
Share Based Compensation (Details) - Schedule of Summarizes Employee and Non-Employee Stock Option Activity [Table]
Restricted cash
Restricted Cash, Noncurrent
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Class of Stock [Domain]
Severance pay
Severance Costs
Schedule of Intellectual Property Capitalized
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive income (loss)
Ordinary shares, shares outstanding
Common Stock, Shares, Outstanding
Finite-Lived Intangible Assets, Major Class Name [Domain]
Fifth Amendment Research Collaboration and License Agreement [Member]
Fifth amendment research collaboration and license agreement
Research and development incentives receivable
Research and development incentives receivable.
Research And Development Incentives Receivable
Share Based Compensation (Details) [Table]
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
American Depositary Shares
American Depositary Shares Member
ADS Warrants [Member]
ADS [Member]
Antidilutive Securities [Axis]
Fair Value Measurements [Line Items]
Entity Interactive Data Current
Milestone payment
Milestone payment.
Document Quarterly Report
Schedule of Intellectual Property Capitalized [Line Items]
Consolidated Entities [Axis]
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Total cash, cash equivalents, and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Expiration Date
Warrants expiration date.
Warrant Expiration Date
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Statistical Measurement [Axis]
Total
Operating Lease, Cost
Milestone Payments Receivable
Milestone payments receivable.
Milestone payments receivable
Schedule of Effect of Lease Costs in our condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Number of shares available for grant
Expected Milestone Payments
Expected milestone payments.
Expected milestone payments
Issuance of freestanding financial instruments
Equity Issued in Business Combination, Fair Value Disclosure
Effect of exchange rate on changes on cash, cash equivalents, and restricted cash
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Research and Development Costs
Research and Development Expense, Policy [Policy Text Block]
Total assets
Assets
Classification
Classification of warrants.
Classificationo FWarrants
Recently Adopted Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Entity Address, City or Town
Revision of Prior Period, Adjustment [Member]
Correction [Member]
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent [Member]
Stock issuance costs
Net of issuance costs
Payments of Stock Issuance Costs
Net issue costs associated with ADS shares and ADS pre-funded warrants
Contingent Consideration
The disclosure of contingent consideration.
Contingent Consideration Text Block
Schedule of Operating and Finance Leases [Abstract]
Deferred tax liability
Increase (Decrease) in Deferred Liabilities
Revision of Prior Period [Domain]
Share Based Compensation
Share-Based Payment Arrangement [Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Number of shares available for issuance
Weighted average remaining lease percentage
Operating Lease, Weighted Average Discount Rate, Percent
Fair Value Measurement [Abstract]
2024 accompanying ADS warrants [Member]
Twenty Twenty Four Accompanying ADSWarrants Member
Twenty Twenty Four Accompanying ADS Warrants Member
Issuance of shares, net of issuance costs
Stock Issued During Period, Value, New Issues
Issuance of ADS shares/Common stock in connection with ATM facility, net of issuance costs and stock subscription receivable
Exercise of pre-funded ADS warrants
Exercise of common stock options
Stock Issued During Period, Value, Stock Options Exercised
Current liabilities:
Liabilities, Current [Abstract]
Stock issued pursuant to a subscription receivable
Stock Issued Pursuant To Subscription Receivable
Stock issued pursuant to subscription receivable.
Fair Value Measurement (Details) - Schedule of Company’s Liabilities at Fair Value on a Recurring Basis [Table]
Professional and consulting fees
Accrued Professional And Consulting Fees Current
Accrued professional and consulting fees current.
Bionomics Limited [Member]
Bionomics Limited Member
Document Type
Title of 12(b) Security
Payment of Milestone Obligation to Eclipse
Payment of milestone obligation to Eclipse.
Payment of milestone obligation to Eclipse
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Related Party Transactions (Details) [Table]
Schedule of Effect of Lease Costs in our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
Lease, Cost [Table Text Block]
Statement of Stockholders' Equity [Abstract]
Balance at beginning
Balance at ending
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Document Fiscal Period Focus
Schedule of Company's Entity Structure at the End of the Reporting Period [Line Items]
Research and Development Expense, Total
Research and development
Research and Development Expense
Schedule of Carrying Value of Goodwill
Schedule of Goodwill [Table Text Block]
Cash as restricted cash
Restricted Cash and Cash Equivalents
Subsequent Event Type [Domain]
Leases
Lessee, Leases [Policy Text Block]
Schedule of Weighted-Average Assumptions Used in Calculating the Fair Value of the Awards
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Warrants (Details) - Schedule of Classification, Expiration Date, and Exercise Price of Individual Warrants [Table]
Warrants Details Scheduleof Classification Expiration Dateand Exercise Priceof Individual Warrants Table
Warrants To Purchase Common Stock [Member]
Warrants To Purchase Common Stock [Member]
Warrants to purchase common stock.
Error Correction [Table]
Schedule Of Company SLiabilities At Fair Value On ARecurring Basis Abstract
Accounting Changes and Error Corrections [Abstract]
Weighted Average Exercise Price, Beginning Balance
Weighted Average Exercise Price, Ending Balance
Exercise Price
Class of Warrant or Right, Exercise Price of Warrants or Rights
price per share
Financial Instruments [Domain]
Schedule of Warrant Activity [Line Items]
Schedule of Classification, Expiration Date, and Exercise Price of Individual Warrants [Line Items]
Warrants [Line Items]
Percentage of Paid Royalties
Percentage of paid royalties
Paid royalties
Revenue from Contract with Customer, Excluding Assessed Tax
Revenue
Merck and Co Inc [Member]
Merck and Co Inc.
Merck & Co., Inc. [Member]
Income Taxes
Income Tax Disclosure [Text Block]
Consolidated Entities [Domain]
Warrants [Abstract]
Number of ADS Warrants, Exercised
Class of Warrant or Right, Exercised
Class of warrant or right, exercised.
Net book value
Finite-Lived Intangible Assets, Net
Depreciation and amortization expense
Depreciation, Depletion and Amortization, Nonproduction
Other
Other Accrued Liabilities, Current
Accounts payable
Increase (Decrease) in Accounts Payable
Document Period End Date
Net Cash Provided by (Used in) Financing Activities
Net cash provided by financing activities
Employee Benefits and Share-Based Compensation
Recognized total stock-based compensation expense (in Dollars)
Effective income tax rate
Total income tax benefit percentage
Effective Income Tax Rate Reconciliation, Percent
Stockholders' Equity Note [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Potential shares of common stock are anti-dilutive
Goodwill
Goodwill Disclosure [Text Block]
Research and development
Other Research and Development Expense
Income tax benefit
Income Tax Expense (Benefit), Total
Total income tax benefit
Income Tax Expense (Benefit)
Income tax benefit (expense)
Trading Symbol
Total shareholders’ equity
Balance
Balance
Equity, Attributable to Parent
Fair Value, Option, Changes in Fair Value, Gain (Loss)
Gain (loss) on fair value adjustments
Long-Lived Tangible Asset [Axis]
Number of ADS Warrants, Ending Balance
Number of ADS Warrants, Beginning Balance
Number of ADS Warrants Outstanding
Class of Warrant or Right, Outstanding
Other non-current liabilities
Other Liabilities, Noncurrent
Share-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Restricted Stock Units (RSUs) [Member]
Related Party Transactions [Abstract]
Schedule Of Company SEntity Structure At The End Of The Reporting Period Abstract
Accrued Research and Development Costs
In Process Research and Development, Policy [Policy Text Block]
Carrying amount, Beginning
Carrying amount, Ending
Goodwill
Goodwill
Schedule of Accounts Receivable, Non-Trade
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
Measurement Input Type [Axis]
Unrecognized compensation cost (in Dollars)
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Leases [Abstract]
Schedule Of Intellectual Property Capitalized Abstract
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Recognized agreement termination fee paid
Payment Of Recognized Agreement Termination Fee
Payment of recognized agreement termination fee.
WG Partners LLP [Member]
WGPartners LLPMember
Selling shareholder's ownership percentage
Selling shareholder's ownership percentage.
Selling shareholder's ownership percentage
Share-based compensation
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition
Key Employee [Member]
Key employee.
Key Employee [Member]
Insurance
Accrued Insurance, Current
Class of Stock [Line Items]
KV One point Three Compound [Member]
KV 1.3 Compound.
Kv1.3 Compounds [Member]
Intellectual property capitalized
Intellectual Property Capitalized
Intellectual property capitalized.
Dividend yield
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Security Exchange Name
Schedule of Accounts Receivable, Non-Trade [Abstract]
Counterparty Name [Domain]
Total operating expenses
Operating Expenses
Weighted average grant date fair value (in Dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Long-Lived Tangible Asset [Domain]
Class of Stock [Axis]
Fair Value Measurement
Fair Value Disclosures [Text Block]
Interest receivable
Interest Receivable, Current
Error Correction [Text Block]
Immaterial Correction of Prior Quarter Error
Subsequent Event [Member]
Subsequent Event [Member]
Maximum [Member]
Maximum [Member]
Total liabilities and shareholders’ equity
Liabilities and Equity
Dr. Spyros Papapetropoulos [Member]
Dr Spyros Papapetropoulos Member
Dr Spyros Papapetropoulos.
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Prepaid insurance expense
Prepaid Expense, Current
Net income per share - diluted
Net income (loss) per share - diluted
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Post-tax discount rate
Post tax discount date percentage.
Post Tax Discount Rate Percentage
Freestanding Financial Instruments Accompanying Warrant Liability [Member]
Freestanding Financial Instruments Accompanying Warrant Liability Member
Entity Ex Transition Period
Total liabilities
Liabilities
Common Stock, Voting Rights
Common stock, voting rights
Fair Value Hierarchy and NAV [Domain]
Total current assets
Assets, Current
Stock issued during period, shares
Stock Issued During Period, Shares, New Issues
Issuance of ADS shares/Common stock in connection with ATM facility, net of issuance costs and stock subscription receivable (in Shares)
Vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Entity Filer Category
Share issue costs
Share issue cost
Share issue cost
Schedule of Company’s Entity Structure at the End of the Reporting Period
Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block]
Property and Equipment, Net [Abstract]
Increase (Decrease) in Contingent Consideration
Increase (decrease) in contingent consideration.
Contingent consideration
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies [Policy Text Block]
Summary of significant accounting policies, policy text block.
Other income (loss):
Nonoperating Income (Expense) [Abstract]
Current Fiscal Year End Date
Schedule Of Warrant Activity Abstract
Property and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Less: Imputed interest
Less: effect of discounting
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Share-based compensation
Share-Based Payment Arrangement, Noncash Expense
Aggregate Intrinsic Value, Outstanding Beginning Balance
Aggregate Intrinsic Value, Outstanding Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Entity
Subsidiary of Limited Liability Company or Limited Partnership, Managing Member or General Partner
Share Based Compensation [Line Items]
Foreign currency exchange differences
Goodwill, Foreign Currency Translation Gain (Loss)
Non-qualified stock options
Non-qualified Stock Options
Non-qualified stock options.
Employee share plan
Employee Stock Ownership Plan (ESOP), Deferred Shares
Entity Registrant Name
Registrant Name
Number reportable segment
Number of Reportable Segments
Net Income (Loss) per Share
Earnings Per Share [Text Block]
Entity Emerging Growth Company
Weighted average shares - basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average common shares outstanding - basic
Weighted Average Number of Shares Outstanding, Basic
Contingencies [Line Items]
Common Stock, Shares Authorized
Common stock, shares authorized
Estimated Useful Life
Property, Plant and Equipment, Useful Life
Proceeds from Issuance of Common Stock
Net proceeds
Proceeds from the sale of equity, net of issuance costs
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 1 [Member]
Amortization expense
Amortization of Intangible Assets
Financial Instrument [Axis]
Weighted Average Remaining Contractual Term, Outstanding Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Accounts Receivable, Non-trade
Accounts and Nontrade Receivable [Text Block]
Revenue [Policy Text Block]
Revenue Recognition
Share Based Compensation [Abstract]
Impairment of Long-Lived Assets
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Sign-on bonus
Signing on bonus.
Bonus
Commitments and Contingencies
Contingencies Disclosure [Text Block]
Fundraising proceeds percentage
Fundraising Proceeds Percentage
Summary of Significant Accounting Policies [Abstract]
Schedule of Summarizes Employee and Non-Employee Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Income Taxes [Abstract]
Shareholders’ equity:
Equity, Attributable to Parent [Abstract]
Net Income (Loss) Attributable to Parent, Diluted
Net income plus assumed conversion of accompanying warrants
Cash Equivalents, Restricted Cash, and Investments
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Statement [Table]
Segment Reporting
Segment Reporting, Policy [Policy Text Block]
Schedule of Property and Equipment, Net
Property, Plant and Equipment [Table Text Block]
Weighted average period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Subsequent Event [Table]
Accrued Expenses and Other Current Liabilities [Abstract]
Earnings per share - diluted:
Earnings Per Share, Diluted [Abstract]
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Change in fair value of accompanying warrant liability
Fair Value Adjustment of Warrants
Securities Act File Number
Eligible to Receive Development, Regulatory Milestone Payments
Eligible to receive development, regulatory milestone payments
Eligible to receive development, regulatory milestone payments
Effect of exchange rate on changes on cash, cash equivalents, and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net increase (decrease) in cash, cash equivalents, and restricted cash
Net Income (Loss) per Share [Abstract]
weighted average remaining contractual life
Warrants and Rights Outstanding, Term
Statement of Financial Position [Abstract]
Operating Income (Loss)
Income (loss) from operations
Renew or extend term
Lessor, Operating Lease, Renewal Term
Ordinary shares, no par value (in Dollars per share)
Ordinary shares, par value (in Dollars per share)
Par value per share
Common Stock, No Par Value
Entity Shell Company
Professional fees
Accrued Professional Fees, Current
Entity Tax Identification Number
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
Summary of Immaterial Corrections to Previously Reported Financial Statements
Class of Warrant or Right [Domain]
Fair Value of Financial Instruments
Fair Value of Financial Instruments, Policy [Policy Text Block]
Entity Current Reporting Status
Weighted Average Remaining Contractual Term, Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Schedule of Company’S Liabilities at Fair Value on a Recurring Basis
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Neuphoria Therapeutics Inc. [Member]
Neuphoria Therapeutics Inc [Member]
Neuphoria Therapeutics Inc.
Two Thousand Twenty Four Equity Incentive Plan [Member]
Two thousand twenty four equity incentive plan.
2024 Equity Incentive Plan [Member]
Subsequent Events [Abstract]
Previously Reported [Member]
As Reported [Member]
Document Fiscal Year Focus
General and administrative
Other General and Administrative Expense
Asset Acquisition, Contingent Consideration, Liability
Liability
Liability
Options to Purchase Common Stock [Member]
Options to Purchase Common Stock [Member]
Options to purchase common stock.
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Tax
City Area Code
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Net of Foreign Currency Effect Period Increase (Decrease)
fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, net of foreign currency effect period increase (decrease).
Change in fair value, net of foreign currency effect
EDA Loan
EDA Loan.
EDALoan
Total current liabilities
Liabilities, Current
Total accrued expenses and other current liabilities
Accrued expenses and other current liabilities
Accrued Liabilities and Other Liabilities
Schedule of Carrying Value of Goodwill [Abstract]
The Company and Basis of Presentation [Abstract]
Local Phone Number
Schedule of Potential Ordinary Shares [Line Items]
Reimbursement amount per month
Payments to Employees
Additional paid in capital
Additional paid-in capital
Additional Paid in Capital
Schedule Of Classification Expiration Date And Exercise Price Of Individual Warrants Abstract
Schedule Of Classification Expiration Date And Exercise Price Of Individual Warrants Abstract
Income Taxes
Income Tax, Policy [Policy Text Block]
Transitional payment
Agreed transitional payable.
Transitional Payment
Commitments and Contingencies [Abstract]
Number of Options, Lapsed
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period
Schedule of Classification, Expiration Date, and Exercise Price of Individual Warrants
Tabular disclosure of classification, expiration date, and exercise price of individual warrants.
Schedule Of Classification Expiration Date And Exercise Price Of Individual Warrants Table Text Block
Current operating lease liabilities
Operating lease liability
Operating lease liability, short-term
Operating Lease, Liability, Current
Error Correction, Previously Immaterial [true false]
Accumulated Deficit
Retained Earnings [Member]
Earnings per share - basic:
Earnings Per Share, Basic [Abstract]
Document Transition Report
Bionomics, Inc. [Member]
Bionomics Inc Member
Class of Warrant or Right, Issued
Class of warrant or right, issued.
Class of warrant or right, issued
Antidilutive Security, Excluded EPS Calculation [Table]
VDA Compounds [Member]
VDA Compound [Member]
VDA Compound [Member]
Schedule of Change in Fair Value of the Contingent Consideration Liability [Line Items]
Schedule of Company's Liabilities at Fair Value on a Recurring Basis [Line Items]
Schedule of Fair Value was Determined by Level 3 Inputs [Line Items]
Concentration of Credit Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Common stock issuable, shares
Common stock issuable, shares
Common stock issuable, shares.
Minimum [Member]
Ordinary Shares
Common Stock [Member]
Common Shares
Restricted cash
Restricted Cash
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Foreign Currency Translation
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
2026
Lessee, Operating Lease, Liability, to be Paid, Year One
Stock Subscription Receivable
Stock Subscription Receivable [Member]
Stock subscription receivable.
Realized Gain (Loss), Foreign Currency Transaction, before Tax
Gain (loss) on foreign currency transactions
Entity Common Stock, Shares Outstanding
Fair Value Measurement (Tables) [Table]
Accrued expenses and other current liabilities
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Title and Position [Domain]
Exchange of no-par stock for par stock
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Accompanying warrants liability
Warrant liability
Warrants and Rights Outstanding
Service paid
The amount of services paid.
Paid For Services
Lease payments percentage
Lease payments percenatage.
Lease Payments Percenatage
Ordinary shares, no par value; 1,468,735,424 shares issued and outstanding at June 30, 2023
Common Stock, Value, Issued
Common stock, $0.00001 par value, 1,853,966 and 1,103,954 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Interest income, net
Investment Income, Interest
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities
Less: effect of revaluation of accompanying warrant liability
Employee Share A Plan [Member]
Employee Share APlan Member
Schedule Of Potential Ordinary Shares Abstract
Present value of operating lease liability
Total operating lease liability
Present value of operating lease liability
Operating Lease, Liability
Measurement Frequency [Axis]
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
Commitments and Contingencies
Commitments and contingencies (Note 17)
Weighted average shares - diluted
Weighted-average common shares outstanding - diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Total accounts receivable, non-trade
Accounts receivable, non-trade
Accounts Receivable, after Allowance for Credit Loss, Current
Remaining lease payments
Remaining lease payments
Lessee, Operating Lease, Liability, to be Paid
GSTReceivables
GST receivables
Value of gst receivables.
Entity Small Business
Schedule of Presentation Under IFRS and U.S. GAAP
Tabular disclosure of the various types of trade accounts presentation.
Schedule Of Presentation Table Text Block
Entity Bankruptcy Proceedings, Reporting Current
Stockholders' Equity Note, Stock Split, Conversion Ratio
Conversion ratio
Effect of foreign currency remeasurement
Gain (Loss), Foreign Currency Transaction, before Tax
Intangible Assets [Abstract]
Schedule Of Useful Lives Of The Property And Equipment Abstract
Common Stock, Conversion Basis
Conversion ratio description
Employee Share Plan [Member]
Employee Share Plan Member
Dr. De Souza [Member]
Dr De Souza Member
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Weighted Average Exercise Price per Share, Outstanding Beginning Balance
Weighted Average Exercise Price per Share, Outstanding Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Accrued Expenses and Other Current Liabilities
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Liabilities:
Liabilities
Liabilities [Abstract]
Carrying amount, Balance
Carrying amount, Balance
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Measurement Frequency [Domain]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Total other comprehensive loss:
Fair Value, Inputs, Level 3 [Member]
Fair Value, Inputs, Level 3 [Member]
Weighted average remaining lease term
Operating Lease, Weighted Average Remaining Lease Term
Subsequent Events
Subsequent Events [Text Block]
Warrants
The entire disclosure on information about warrants.
Warrants Text Block
Carina Biotech [Member]
Carina Biotech.
Accounts payable
Accounts Payable, Current
Total liabilities measured at fair value
Liabilities, Fair Value Disclosure